HHM Wealth Advisors’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

HHM Wealth Advisors’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-483	Closed	-$10K	–	716
2021 Q3	$10K	Buy	+483	New	+$13.3K	﹤0.01%	494

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

HHM Wealth Advisors's DRNA Position: Q4 2021 in Review

HHM Wealth Advisors sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 483 shares — an estimated $10K sold.

HHM Wealth Advisors first reported a position in DRNA in Q3 2021 and held it in 1 quarter. The position peaked at $10K in Q3 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

HHM Wealth Advisors reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
HHM Wealth Advisors sold 483 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $10K.
HHM Wealth Advisors first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2021 and held it in 1 quarter.
HHM Wealth Advisors's Dicerna Pharmaceuticals, Inc. position peaked at $10K in Q3 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on HHM Wealth Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.